Vanta Diagnostics entered 2026 with a new name and an expanded vision for its role as a national diagnostics platform. By July, it had dramatically expanded its capabilities by acquiring Genomind’s genetic testing operations and growing its footprint to four CAP- and CLIA-certified laboratories serving 45 states. That growth also created an operational challenge.